A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers
about
A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Study of the Combination of ...... tatic EGFR Mutant Lung Cancers
@en
type
label
A Study of the Combination of ...... tatic EGFR Mutant Lung Cancers
@en
prefLabel
A Study of the Combination of ...... tatic EGFR Mutant Lung Cancers
@en
P4844
P1476
Phase 1 Study of Combination O ...... rrent RB1 and TP53 Alterations
@en
P3098
NCT03567642
P580
2018-06-12T00:00:00Z
P582
2020-06-01T00:00:00Z